PCN26 - Estimating The Potential Budget Impact Of Zelboraf (Vemurafenib) For Advanced Melanoma Treatment In Brazilian Private Health Care System

Autor: Tsuchiya, C.T., Buschinelli, C.T., M.F.M., Maximo, Tobaruella, F.S., Borges, L.G.
Zdroj: In Value in Health May 2013 16(3):A132-A132
Databáze: ScienceDirect